General Information
Revision date
2020-10-10
Product name
Olmesartan / Amlodipine Besylate (3.5%) / Hydrochlorothia- zide Formulation
1.2.1 Relevant identified uses
Pharmaceutical
Emergency telephone
1-908-423-6000
Icons in SDS
Company Information
company name
MSD
e-mail address of the competent person responsible for the Safety Data Sheet
EHSDATASTEWARD@msd.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H319, H360D, H373, H412
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
CLP CLASSIFICATION
Eye irritation, Category 2 H319: Causes serious eye irritation. Reproductive toxicity, Category 1A H360D: May damage the unborn child. Specific target organ toxicity - repeated H373: May cause damage to organs through pro- exposure, Category 2 longed or repeated exposure. Long-term (chronic) aquatic hazard, Cat- H412: Harmful to aquatic life with long lasting ef- egory 3 fects.
2.2 Label elements
REGULATION (EC) No 1272/2008)
Signal word
Danger
Hazard statements
H319 Causes serious eye irritation. H360D May damage the unborn child. H373 May cause damage to organs through prolonged or repeated exposure. H412 Harmful to aquatic life with long lasting effects.
Prevention
P201 Obtain special instructions before use. P264 Wash skin thoroughly after handling. P273 Avoid release to the environment. P280 Wear protective gloves/ protective clothing/ eye protec- tion/ face protection.
Response
P308 + P313 IF exposed or concerned: Get medical advice/ attention. P337 + P313 If eye irritation persists: Get medical advice/ attention.
Hazardous Ingredients
Olmesartan Hydrochlorothiazide
2.3 Other hazards
None known.
